Clinical Trial Update: Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study comparing exemestane plus dasatinib versus placebo in advanced estrogen receptor-positive breast cancer to evaluate safety and efficacy, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DASATINIB (Dasatinib)
• Exemestane (Exemestane)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-06-11